Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This randomized controlled trial aims at evaluating the efficacy and safety of the
antidiabetics metformin versus empagliflozin on chronic kidney disease (CKD) progression in
patients with CKD stages 2 or/and 3.